Efficient Hybrid DDPG Task Scheduler for HPC and HTC in Cloud Environment Task Scheduling is a crucial challenge in cloud computing as diversified tasks come rapidly onto cloud console dynamically ...

Sanofi’s Sarclisa receives European approval to treat transplant-eligible newly diagnosed multiple myeloma ...

The GMMG-HD7 protocol defined two primary endpoints: MRD negativity following induction therapy in the first part of the study, and PFS after the second randomization post-transplant in the second ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd ...

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase 3 study demonstrating that Sarclisa with VRd induction ...

He was Involved in XR before the first HTC VIVE was even launched, Thomas Dexmier, the Vice-President of Sales and Marketing for HTC VIVE in EMEA, has a very busy career in tech. What makes him tick?